Literature DB >> 16406795

No difference in expression of apoptosis-related proteins and apoptotic morphology in control, pathologically aged and Alzheimer's disease cases.

Adele Woodhouse1, Tracey C Dickson, Adrian K West, Catriona A McLean, James C Vickers.   

Abstract

Apoptotic-like changes in the neocortex of control, pathologically aged and Alzheimer's disease (AD) cases were investigated. There was no increase in labeling or change in localization of labeling that distinguished between these cases for active caspase-3, -8, -9, Bax, Bcl-2 or TRADD. Bax, Bcl-2 and TRADD mRNA levels also differed little between case types, although there were small but significant decreases in Bax mRNA levels in AD compared to control cases and Bcl-2 mRNA in AD cases compared to pathologically aged and control cases. There was no difference in the percentage of apoptotic-like nuclei between these cases, except for a small but significant decrease in the inferior temporal gyrus of AD cases relative to controls. Nuclei observed within or adjacent to beta-amyloid plaques were rarely abnormal, and neurons bearing neurofibrillary tangles (NFTs) did not have abnormal nuclei. Apoptosis may not play a major role in the pathogenesis of neuronal degeneration of AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406795     DOI: 10.1016/j.nbd.2005.11.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  10 in total

1.  Differential nigral expression of bcl-2 protein family in the pure and common forms of Dementia with Lewy bodies: relevance for dopaminergic neuronal vulnerability.

Authors:  M Saldaña; E Aguilar; M Bonastre; C Marin
Journal:  J Neural Transm (Vienna)       Date:  2007-07-04       Impact factor: 3.575

Review 2.  Neuropathological alterations in Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Matthew P Frosch; Eliezer Masliah; Bradley T Hyman
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

3.  Differential regulation of inhibitors of apoptosis proteins in Alzheimer's disease brains.

Authors:  Lori-Ann Christie; Joseph H Su; Christina H Tu; Malcolm C Dick; Jun Zhou; Carl W Cotman
Journal:  Neurobiol Dis       Date:  2007-01-03       Impact factor: 5.996

Review 4.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

Review 5.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

6.  Tau acetylates and stabilizes β-catenin thereby promoting cell survival.

Authors:  Enjie Liu; Qiuzhi Zhou; Ao-Ji Xie; Xiaoguang Li; Mengzhu Li; Jinwang Ye; Shihong Li; Dan Ke; Qun Wang; Zhi-Peng Xu; Li Li; Ying Yang; Gong-Ping Liu; Xiao-Chuan Wang; Hong-Lian Li; Jian-Zhi Wang
Journal:  EMBO Rep       Date:  2020-01-13       Impact factor: 8.807

Review 7.  Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling.

Authors:  Adrienne M Gorman
Journal:  J Cell Mol Med       Date:  2008-06-27       Impact factor: 5.310

Review 8.  Basic mechanisms of neurodegeneration: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2010-01-11       Impact factor: 5.310

Review 9.  Defining the earliest pathological changes of Alzheimer's disease.

Authors:  James C Vickers; Stan Mitew; Adele Woodhouse; Carmen M Fernandez-Martos; Mathew T Kirkcaldie; Alison J Canty; Graeme H McCormack; Anna E King
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

10.  Roles of receptor-interacting protein kinase 1 in SH-SY5Y cells with beta amyloid-induced neurotoxicity.

Authors:  Hong-Hao Chan; Chee-Onn Leong; Chooi-Ling Lim; Rhun-Yian Koh
Journal:  J Cell Mol Med       Date:  2022-02-02       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.